Riskpilot← Back to searchSign inGet full accessPartnerMed AB
ABActiveOrg 5567605521StrömstadWholesale of pharmaceutical and medical goods · NACE 4646Est. 20083 employees
Revenue 2024
SEK 36,1M
+8% vs 2023
EBITDA margin
6.4%
-15% vs 2023
Equity ratio
30.6%
Financial strength
Net profit 2024
SEK 1,9M
-13% vs 2023
| Revenue | SEK 36,1M | +8% |
| EBITDA | SEK 2,3M | -15% |
| Net profit | SEK 1,9M | -13% |
| Total assets | SEK 11,6M | +10% |
| Equity | SEK 3,6M | -24% |
| Employees | 3 | — |
Legal name
PartnerMed AB
Org number
5567605521
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1 juli 2008
Share capital
SEK 110 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Setterberg Andersen, Trine L
Company purpose
Föremålet för bolagets verksamhet är att bedriva marknadsföring och försäljning av hälsorelaterade produkter samt därmed förenlig verksamhet.
Address
Strömstad
Email
trine@partnermed.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 23 245 | 24 895 | 25 958 | 26 586 | 29 152 | 33 551 | 36 136 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 1 985 | 1 940 | 2 445 | 2 278 | 2 762 | 5 680 | 3 045 | 2 931 | 2 741 | 2 326 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 1 985 | 1 940 | 2 445 | 2 278 | 2 762 | 5 680 | 3 045 | 2 931 | 2 741 | 2 326 |
| Net financials | −3 | 1 | — | — | −7 | −7 | −6 | −14 | 8 | 77 |
| Profit before tax | 1 982 | 1 941 | 2 444 | 2 477 | 2 074 | 5 674 | 3 720 | 2 918 | 2 750 | 2 403 |
| Tax | −437 | −428 | −538 | −545 | −444 | −1 216 | −774 | −604 | −566 | −499 |
| Net profit | 1 545 | 1 513 | 1 906 | 1 932 | 1 630 | 4 458 | 2 946 | 2 314 | 2 184 | 1 904 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 5 456 | 5 429 | 5 278 | 8 054 | 8 080 | 14 058 | 12 563 | 14 013 | 10 599 | 11 606 |
| Equity | 2 266 | 3 778 | 3 185 | 3 617 | 3 748 | 8 205 | 6 152 | 6 465 | 4 649 | 3 553 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 990 | 1 451 | 1 893 | 4 437 | 3 652 | 5 173 | 6 411 | 7 548 | 5 950 | 8 053 |
| Total debt | 2 990 | 1 451 | 1 893 | 4 437 | 3 652 | 5 173 | 6 411 | 7 548 | 5 950 | 8 053 |
EBITDA margin
6.4%
This company
15.8%
Market median
-59% vs market
20152024
Equity ratio
30.6%
This company
38.2%
Market median
+20% vs market
20152024
Return on equity
53.6%
This company
18.4%
Market median
+191% vs market
20152024
Net profit margin
5.3%
This company
8.1%
Market median
-35% vs market
20152024
Asset turnover
3.11×
This company
1.12×
Market median
+178% vs market
20152024
Debt / equity
2.27×
This company
0.62×
Market median
-266% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BA Audit | Audit | 2021 | — | — |
BI Authorized Recipient of Service | Authorized Recipient of Service | 2021 | — | — |
CM Authorized Recipient of Service | Authorized Recipient of Service | 2024 | — | — |
GR Chief Auditor | Chief Auditor | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PartnerMed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bo Anders Willforss | Audit | 0 companies |
| Berit Irene Faager Berg | Authorized Recipient of Service | 0 companies |
| Camilla Marie Bergenheim | Authorized Recipient of Service | 0 companies |
| Gustaf Ragnar Emanuel Albin | Chief Auditor | 0 companies |
| Lars Erik Andersen | Board of Directors | 0 companies |
| Trine L Setterberg Andersen | Chairman | 0 companies |
| Lasse Setterberg Andersen | Board of Directors | 0 companies |